series-c-plus
Stage
1
Investors
About
BioCryst Pharmaceuticals discovers, develops, and commercializes oral small-molecule and injectable protein therapeutics primarily targeting rare diseases such as hereditary angioedema.
Explore BioCryst Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.